Page 4 - Davidj Mazzo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lisata Therapeutics Receives $2 2 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

Lisata Therapeutics Receives $2 2 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesDavidj mazzoExchange commissionLisata therapeutics incLisata therapeutics inc john mendittoviceJersey economic development authorityCend therapeutics incNew jersey economic development authorityNew jersey basedChief executive officerPrivate securities litigation reform actCend therapeuticsNasdaq capital marketAnnual reportInc john mendittovice president

Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update – Padovanews

Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

John mendittoDavidj mazzoDevices agencyCend therapeutics incCorporate communicationsDevelopment portfolioLisata therapeutics incExchange commissionLisata therapeuticsChief executive officerCendr platformMedical devices agencyKey opinion leadersData safety monitoring boardGlomerular filtration rateFull year

Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics

Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomFrance generalBritish columbiaHeidi hensonDavid mazzoMohammad azabJohn mendittoSteve kloskDavid slackGregory brownErkki ruoslahtiDavidj mazzoCaladrius biosciences incCend therapeutics incIntradigm corporation in palo alto

Caladrius (CLBS) and Cend Close Merger, Rebrands as Lisata Therapeutics

Caladrius (CLBS) and Cend Close Merger, Rebrands as Lisata Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Caladrius Biosciences (CLBS) Announces Approval of Merger and Name Change to Lisata Therapeutics

Caladrius Biosciences (CLBS) Announces Approval of Merger and Name Change to Lisata Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Davidj mazzoCaladrius biosciences inc to lisata therapeuticsCaladrius biosciences incLisata therapeutics incWall streetCend therapeuticsCaladrius boardLisata therapeuticsNasdaq capital marketChief executive officer